US Patent Issued to ELI LILLY and Co. on Sept. 22 for "Incretin analogs and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,999, issued on Sept. 22, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Incretin analogs and uses thereof" was invented by Jorge Alsina-Fernandez (Indianapolis), Tamer Coskun (Carmel, Ind.), Lili Guo (Carmel, Ind.) and Hongchang Qu (Carmel, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Incretin analogs are provided that have activity at each of the GIP, GLP-1 and glucagon receptors. The incretin analogs have structural features resulting in balanced activity and extended duration of action at each of these receptors. Methods also are provided for treating diseases such as diabetes mellitus, dyslipidemia, fatty liver disease, metabolic...